Stay up to date with the latest research, tips, and trends in fitness, nutrition, and weight management.
When stem cells are injected into thick tissues, they often clump together and die from lack of oxygen or nutrients, making it almost impossible to use them for thick, highly vascularized tissues like organ transplants or muscle repair.
For many people diagnosed with breast cancer, the risk of lymphoedema can come as a surprise; often appearing weeks, months or even years after
For many people diagnosed with breast cancer, the risk of lymphoedema can come as a surprise; often appearing weeks, months or even years after
UCLA researchers have uncovered a hidden weakness in some of the deadliest cancers, revealing a potential new strategy for targeting tumors that have long resisted treatment. Small cell neuroendocrine cancers, aggressive tumors that can arise in the lung, prostate, and ovary, grow rapidly, spread early, and remain extremely difficult to treat. A defining feature of these cancers is the loss of a protective gene called RB, which normally acts as a brake on cell growth. Without RB, cancer cells multiply rapidly and resist many targeted therapies.
CTx1000 designed to clear pathological TDP-43 protein, a central driver of ALS SYDNEY, March 23, 2026 /PRNewswire/ -- Celosia Therapeutics, an Australian biotech company developing advanced
Katsina plans to vaccinate three million children in house-to-house polio campaign aimed at boosting immunisation and child health.
He helped discover cancer-causing genes. Later, as chancellor of the University of California, San Francisco, he led a major expansion.
Imagine a game of chess where your opponent's king is in check. It cannot move, but the game is not over—the piece remains on the board. This is how the body might control HIV on its own: The virus would be contained and unable to replicate or spread, but it would not have been eliminated. This is the goal of Professor Ole Schmeltz Søgaard and an international team of researchers—to enable more patients' immune systems to keep the virus permanently in check without the need for daily medication. Their findings suggest that this requires two key components working in tandem: antibodies and T cells.
/PRNewswire/ -- Celosia Therapeutics, an Australian biotech company developing advanced gene therapies for neurodegenerative diseases, today announced dosing...
/PRNewswire/ -- Celosia Therapeutics, an Australian biotech company developing advanced gene therapies for neurodegenerative diseases, today announced dosing...